Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 2/20 | 0.35 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.34 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | POLA1 | P09884 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14734042 | 0.90 | L3MBTL1 (0.47) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL14733285 | 0.87 | LMNA (0.47) | L3MBTL1TSHRLMNAPPARGPPARA | |
| SCHEMBL14734041 | 0.81 | PPARG (0.47) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL14734258 | 0.81 | L3MBTL1 (0.45) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL14733283 | 0.80 | LMNA (0.49) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL14733284 | 0.80 | LMNA (0.49) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL14733282 | 0.76 | TSHR (0.39) | L3MBTL1TSHRLMNAALDH1A1KMT2A | |
| SCHEMBL14734043 | 0.76 | LMNA (0.50) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL14734044 | 0.76 | LMNA (0.50) | L3MBTL1TSHRLMNAALDH1A1PPARG | |
| SCHEMBL6829456 | 0.72 | L3MBTL1 (0.53) | L3MBTL1TSHRLMNAALDH1A1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8835663-B2 | Lubricity improver | KOREA INSTITUTE OF PETROLEUM MANAGEMENT (KR) | 2014-09-16 | — | — | US | disclosed |
| US-20130053590-A1 | LUBRICITY IMPROVER | KOREA INSTITUTE OF PETROLEUM MANAGEMENT (KR) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053590-A1 | LUBRICITY IMPROVER | ELOVL1, ELOVL5, FASN | L3MBTL1 3484/4885TSHR 4404/4885LMNA 3849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.